Phase 1 Study of Intravenous Oncolytic Poxvirus (vvDD) in Patients With Advanced Solid Cancers

Molecular Therapy - United States
doi 10.1038/mt.2016.101
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

A Phase 1 Study of Oral Ridaforolimus in Pediatric Patients With Advanced Solid Tumors

Oncotarget
Oncology
2016English

Correction: Phase 2 Study of Pembrolizumab in Patients With Advanced Rare Cancers

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

A Phase IB Trial of 24-Hour Intravenous PX-12, a Thioredoxin-1 Inhibitor, in Patients With Advanced Gastrointestinal Cancers

Investigational New Drugs
OncologyPharmacology
2012English

A Phase 1 Study of Cetuximab and Lapatinib in Patients With Advanced Solid Tumor Malignancies

Cancer
Cancer ResearchOncology
2015English

Phase 1 Dose-Escalation Study of Single-Agent Veliparib in Japanese Patients With Advanced Solid Tumors

Cancer Science
Cancer ResearchMedicineOncology
2017English

A Phase 1, Open-Label, Dose Escalation Study of Intravenous Paricalcitol in Combination With Gemcitabine in Patients With Advanced Malignancies

Cancer
Cancer ResearchOncology
2018English

Anti-Pd-1 Monoclonal Antibody MEDI0680 in a Phase I Study of Patients With Advanced Solid Malignancies

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Phase I Study of TAS-102 Treatment in Japanese Patients With Advanced Solid Tumours

British Journal of Cancer
Cancer ResearchOncology
2012English

Phase I Study of Single-Agent Ribociclib in Japanese Patients With Advanced Solid Tumors

Cancer Science
Cancer ResearchMedicineOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy